Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

GSP 304 (tiotropium bromide) is a mist that Glenmark Pharmaceuticals is developing to widen the narrowed airways that are a hallmark of chronic obstructive pulmonary disease. Glenmark is working on ...

Hoping to increase awareness of an often-debilitating and misdiagnosed lung condition called nontuberculous mycobacterial (NTM) lung disease, the COPD Foundation is hosting a Facebook discussion on ...

Columnist Caroline Gainer had been searching for ways to improve her rest. Now, with help of her Fitbit, she's found her ...

When I was suffering from depression, I couldn’t do my housework the way that I wanted. Now that I’m better, I’m enjoying doing things like pulling weeds and other chores. These activities are also a ...

The active substance delivered by INOpulse is inhaled nitric oxide (iNO). NO is naturally produced by the lining of blood vessels as a vasodilator, a compound that acts to relax the smooth muscle ...

Novartis’ Ultibro Breezhaler provided noteworthy improvements in cardiac and lung function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation (overinflated lungs) when ...

I was born a preemie weighing in at 4 pounds, and during my first six years of life, I was plagued with numerous ear infections. I now have chronic obstructive pulmonary disease (COPD). I wondered if ...

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with chronic obstructive pulmonary disease (COPD). The treatment, ...